Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Endo Health sees weak 2013 profit on generic threat to key drug
Endo Health sees weak 2013 profit on generic threat to key drug
Endo Health sees weak 2013 profit on generic threat to key drug
Submitted by
admin
on October 4, 2012 - 11:04am
Source:
Reuters
News Tags:
Endo
generics
lidoderm
Headline:
Endo Health sees weak 2013 profit on generic threat to key drug
Do Not Allow Advertisers to Use My Personal information
